HLS Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:74D Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
14 Nov 24	Sell€1,116	Norma Beauchamp	Individual	500	€2.23
14 Aug 24	Buy€8,435	John Hanna	Individual	4,000	€2.11
15 May 24	Buy€6,671	Craig Millian	Individual	2,500	€2.67

Insider Buying: 74D insiders have only sold shares in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 16 shareholders own 60.49% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
20%	Polar Asset Management Partners Inc.	6,367,082	€15.0m	0%	0.5%
18.8%	Stadium Capital Management, LLC	5,964,842	€14.0m	0%	8.12%
10.2%	Mawer Investment Management Ltd.	3,237,056	€7.6m	0%	0.02%
9.6%	Neuberger Berman Investment Advisers LLC	3,051,782	€7.2m	0%	0.01%
0.78%	Rbc Indigo Asset Management Inc	247,745	€582.1k	0%	0.01%
0.31%	ATB Investment Management Inc.	97,211	€228.4k	0%	no data
0.31%	John Welborn	97,000	€227.9k	0%	no data
0.18%	Dimensional Fund Advisors LP	58,356	€137.1k	-0.24%	no data
0.16%	Jason Gross	49,700	€116.8k	0%	no data
0.085%	Manulife Asset Management	27,000	€63.4k	0%	no data
0.039%	Craig Millian	12,500	€29.4k	0%	no data
0.033%	Highland Capital Management, L.P.	10,445	€24.5k	0%	no data
0.025%	John Hanna	8,000	€18.8k	100%	no data
0.0056%	Kyle Dempsey	1,765	€4.1k	0%	no data
0.0038%	Brian Walsh	1,200	€2.8k	0%	no data
0.0016%	Ryan Lennox	500	€1.2k	0%	no data